400 related articles for article (PubMed ID: 30586746)
1. A Phase 2 Randomized, Sham-Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow-Derived ALD-401 Cells in Patients With Recent Stable Ischemic Stroke (RECOVER-Stroke).
Savitz SI; Yavagal D; Rappard G; Likosky W; Rutledge N; Graffagnino C; Alderazi Y; Elder JA; Chen PR; Budzik RF; Tarrel R; Huang DY; Hinson JM
Circulation; 2019 Jan; 139(2):192-205. PubMed ID: 30586746
[TBL] [Abstract][Full Text] [Related]
2. Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial.
Prasad K; Sharma A; Garg A; Mohanty S; Bhatnagar S; Johri S; Singh KK; Nair V; Sarkar RS; Gorthi SP; Hassan KM; Prabhakar S; Marwaha N; Khandelwal N; Misra UK; Kalita J; Nityanand S;
Stroke; 2014 Dec; 45(12):3618-24. PubMed ID: 25378424
[TBL] [Abstract][Full Text] [Related]
3. Intra-arterial bone marrow mononuclear cells (BM-MNCs) transplantation in acute ischemic stroke (IBIS trial): protocol of a phase II, randomized, dose-finding, controlled multicenter trial.
Moniche F; Escudero I; Zapata-Arriaza E; Usero-Ruiz M; Prieto-León M; de la Torre J; Gamero MA; Tamayo JA; Ochoa-Sepúlveda JJ; Maestre J; Carmona M; Piñero P; Calderón-Cabrera C; Jimenez MD; Gonzalez A; Montaner J
Int J Stroke; 2015 Oct; 10(7):1149-52. PubMed ID: 26044701
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.
Hess DC; Wechsler LR; Clark WM; Savitz SI; Ford GA; Chiu D; Yavagal DR; Uchino K; Liebeskind DS; Auchus AP; Sen S; Sila CA; Vest JD; Mays RW
Lancet Neurol; 2017 May; 16(5):360-368. PubMed ID: 28320635
[TBL] [Abstract][Full Text] [Related]
5. Intra-arterial infusion of autologous bone marrow mononuclear cells in patients with moderate to severe middle cerebral artery acute ischemic stroke.
Friedrich MA; Martins MP; Araújo MD; Klamt C; Vedolin L; Garicochea B; Raupp EF; Sartori El Ammar J; Machado DC; Costa JC; Nogueira RG; Rosado-de-Castro PH; Mendez-Otero R; Freitas GR
Cell Transplant; 2012; 21 Suppl 1():S13-21. PubMed ID: 22507676
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic Stem Cell Therapy for Acute Ischemic Stroke: The Phase 2/3 TREASURE Randomized Clinical Trial.
Houkin K; Osanai T; Uchiyama S; Minematsu K; Taguchi A; Maruichi K; Niiya Y; Asaoka K; Kuga Y; Takizawa K; Haraguchi K; Yoshimura S; Kimura K; Tokunaga K; Aoyama A; Ikawa F; Inenaga C; Abe T; Tominaga A; Takahashi S; Kudo K; Fujimura M; Sugiyama T; Ito M; Kawabori M; Hess DC; Savitz SI; Hirano T;
JAMA Neurol; 2024 Feb; 81(2):154-162. PubMed ID: 38227308
[TBL] [Abstract][Full Text] [Related]
7. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells).
Perin EC; Murphy MP; March KL; Bolli R; Loughran J; Yang PC; Leeper NJ; Dalman RL; Alexander J; Henry TD; Traverse JH; Pepine CJ; Anderson RD; Berceli S; Willerson JT; Muthupillai R; Gahremanpour A; Raveendran G; Velasquez O; Hare JM; Hernandez Schulman I; Kasi VS; Hiatt WR; Ambale-Venkatesh B; Lima JA; Taylor DA; Resende M; Gee AP; Durett AG; Bloom J; Richman S; G'Sell P; Williams S; Khan F; Gyang Ross E; Santoso MR; Goldman J; Leach D; Handberg E; Cheong B; Piece N; DiFede D; Bruhn-Ding B; Caldwell E; Bettencourt J; Lai D; Piller L; Simpson L; Cohen M; Sayre SL; Vojvodic RW; Moyé L; Ebert RF; Simari RD; Hirsch AT;
Circulation; 2017 Apr; 135(15):1417-1428. PubMed ID: 28209728
[TBL] [Abstract][Full Text] [Related]
9. Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial.
Moniche F; Gonzalez A; Gonzalez-Marcos JR; Carmona M; Piñero P; Espigado I; Garcia-Solis D; Cayuela A; Montaner J; Boada C; Rosell A; Jimenez MD; Mayol A; Gil-Peralta A
Stroke; 2012 Aug; 43(8):2242-4. PubMed ID: 22764211
[TBL] [Abstract][Full Text] [Related]
10. The effects of intravenous infusion of autologous mesenchymal stromal cells in patients with subacute middle cerebral artery infarct: a phase 2 randomized controlled trial on safety, tolerability and efficacy.
Law ZK; Tan HJ; Chin SP; Wong CY; Wan Yahya WNN; Muda AS; Zakaria R; Ariff MI; Ismail NA; Cheong SK; S Abdul Wahid SF; Mohamed Ibrahim N
Cytotherapy; 2021 Sep; 23(9):833-840. PubMed ID: 33992536
[TBL] [Abstract][Full Text] [Related]
11. TOOTH (The Open study Of dental pulp stem cell Therapy in Humans): Study protocol for evaluating safety and feasibility of autologous human adult dental pulp stem cell therapy in patients with chronic disability after stroke.
Nagpal A; Kremer KL; Hamilton-Bruce MA; Kaidonis X; Milton AG; Levi C; Shi S; Carey L; Hillier S; Rose M; Zacest A; Takhar P; Koblar SA
Int J Stroke; 2016 Jul; 11(5):575-85. PubMed ID: 27030504
[TBL] [Abstract][Full Text] [Related]
12. Primary Results of the Multicenter ARISE II Study (Analysis of Revascularization in Ischemic Stroke With EmboTrap).
Zaidat OO; Bozorgchami H; Ribó M; Saver JL; Mattle HP; Chapot R; Narata AP; Francois O; Jadhav AP; Grossberg JA; Riedel CH; Tomasello A; Clark WM; Nordmeyer H; Lin E; Nogueira RG; Yoo AJ; Jovin TG; Siddiqui AH; Bernard T; Claffey M; Andersson T
Stroke; 2018 May; 49(5):1107-1115. PubMed ID: 29643261
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte-colony stimulating factor for mobilizing bone marrow stem cells in subacute stroke: the stem cell trial of recovery enhancement after stroke 2 randomized controlled trial.
England TJ; Abaei M; Auer DP; Lowe J; Jones DR; Sare G; Walker M; Bath PM
Stroke; 2012 Feb; 43(2):405-11. PubMed ID: 22198983
[TBL] [Abstract][Full Text] [Related]
14. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
15. Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke.
Gulati A; Agrawal N; Vibha D; Misra UK; Paul B; Jain D; Pandian J; Borgohain R
CNS Drugs; 2021 Jan; 35(1):85-104. PubMed ID: 33428177
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of the Sigma-1 receptor agonist cutamesine (SA4503) for recovery enhancement after acute ischemic stroke.
Urfer R; Moebius HJ; Skoloudik D; Santamarina E; Sato W; Mita S; Muir KW;
Stroke; 2014 Nov; 45(11):3304-10. PubMed ID: 25270629
[TBL] [Abstract][Full Text] [Related]
17. Stem cell transplantation for ischemic stroke.
Boncoraglio GB; Bersano A; Candelise L; Reynolds BA; Parati EA
Cochrane Database Syst Rev; 2010 Sep; (9):CD007231. PubMed ID: 20824857
[TBL] [Abstract][Full Text] [Related]
18. Partial aortic occlusion for cerebral perfusion augmentation: safety and efficacy of NeuroFlo in Acute Ischemic Stroke trial.
Shuaib A; Bornstein NM; Diener HC; Dillon W; Fisher M; Hammer MD; Molina CA; Rutledge JN; Saver JL; Schellinger PD; Shownkeen H;
Stroke; 2011 Jun; 42(6):1680-90. PubMed ID: 21566232
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of intra-arterial bone marrow mononuclear cell transplantation in patients with acute ischaemic stroke in Spain (IBIS trial): a phase 2, randomised, open-label, standard-of-care controlled, multicentre trial.
Moniche F; Cabezas-Rodriguez JA; Valverde R; Escudero-Martinez I; Lebrato-Hernandez L; Pardo-Galiana B; Ainz L; Medina-Rodriguez M; de la Torre J; Escamilla-Gomez V; Ortega-Quintanilla J; Zapata-Arriaza E; de Albóniga-Chindurza A; Mancha F; Gamero MA; Perez S; Espinosa-Rosso R; Forero-Diaz L; Moya M; Piñero P; Calderón-Cabrera C; Nogueras S; Jimenez R; Martin V; Delgado F; Ochoa-Sepúlveda JJ; Quijano B; Mata R; Santos-González M; Carmona-Sanchez G; Herrera C; Gonzalez A; Montaner J
Lancet Neurol; 2023 Feb; 22(2):137-146. PubMed ID: 36681446
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With ST-Segment Elevation Myocardial Infarction and Left Ventricular Dysfunction.
Fernández-Avilés F; Sanz-Ruiz R; Bogaert J; Casado Plasencia A; Gilaberte I; Belmans A; Fernández-Santos ME; Charron D; Mulet M; Yotti R; Palacios I; Luque M; Sádaba R; San Román JA; Larman M; Sánchez PL; Sanchís J; Jiménez MF; Claus P; Al-Daccak R; Lombardo E; Abad JL; DelaRosa O; Corcóstegui L; Bermejo J; Janssens S
Circ Res; 2018 Aug; 123(5):579-589. PubMed ID: 29921651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
